Results 41 to 50 of about 87,239 (208)

Neoadjuvant chemoradiotherapy for esophageal carcinoma

open access: yes, 2005
Neoadjuvant chemoradiotherapy is often administered to patients with esophageal carcinoma in the belief that this will improve survival. However, its role in the management of esophageal carcinoma remains controversial.
Bessell, J.   +14 more
core   +1 more source

Beyond dual targeting: redefining the treatment horizon for true extramedullary myeloma? – a critical appraisal

open access: yesFrontiers in Oncology
The management of relapsed/refractory multiple myeloma with true extramedullary disease (EMD) remains a critical challenge. The phase 2 RedirecTT-1 study evaluated the combination of two bispecific antibodies, talquetamab (anti-GPRC5D) and teclistamab ...
Qinghua Ke, Shiqiong Zhou
doaj   +1 more source

Clinical stage after chemoradiotherapy.

open access: yes, 2014
Clinical stage after chemoradiotherapy.
Meng Su (136681)   +5 more
core   +1 more source

Preoperative versus postoperative chemoradiotherapy for rectal cancer

open access: yes, 2004
BACKGROUND: Postoperative chemoradiotherapy is the recommended standard therapy for patients with locally advanced rectal cancer. In recent years, encouraging results with preoperative radiotherapy have been reported.
Becker, H.   +13 more
core   +1 more source

A unique combination of natural fatty acids from Hermetia illucens fly larvae fat effectively combats virulence factors and biofilms of MDR hypervirulent mucoviscus Klebsiella pneumoniae strains by increasing Lewis acid–base/van der Waals interactions in bacterial wall membranes

open access: yesFrontiers in Cellular and Infection Microbiology
IntroductionHypervirulent Klebsiella pneumoniae (hvKp) and carbapenem-resistant K. pneumoniae (CR-Kp) are rapidly emerging as opportunistic pathogens that have a global impact leading to a significant increase in mortality rates among clinical patients ...
Heakal Mohamed   +5 more
doaj   +1 more source

Improving chemoradiotherapy with nanoparticle therapeutics

open access: yes, 2013
Chemoradiotherapy has been a key treatment paradigm in cancer management. One of the main research objectives in cancer research has been to identify agents and strategies to improve the therapeutic index of chemoradiation.
Wang, Andrew Zhuang   +1 more
core   +1 more source

Predictive Value of Early Response to Chemoradiotherapy in Advanced Esophageal Squamous Cell Carcinoma by Diffusion-Weighted MR Imaging

open access: yesTechnology in Cancer Research & Treatment, 2020
Objective: To explore the value of diffusion-weighted imaging for early response detection of locally advanced esophageal squamous cell carcinoma with concurrent chemoradiotherapy. Methods: Fifty-five (42 males, 13 females) patients with locally advanced
Wei Chen MD   +5 more
doaj   +1 more source

Therapy-Related Acute Myeloid Leukemia 2 Months after Chemoradiotherapy for Esophageal Cancer: A Case Report

open access: yesCase Reports in Oncology, 2020
Therapy-related acute myeloid leukemia (AML) is a rare but potentially fatal adverse event caused by chemotherapy or radiotherapy. Herein we report a patient diagnosed with therapy-related AML 2 months after chemoradiotherapy for esophageal cancer.
Shinya Hiraoka   +5 more
doaj   +1 more source

Paradigms in chemoradiotherapy

open access: yesEuropean Journal of Cancer Supplements, 2007
Abstract The efficacy of radiation in locally advanced non- small cell lung cancer (NSCLC) is limited. In a search for improving the outcome, particular attention has focused on the possibility of combining radi- ation with chemotherapy. The two most frequently used combined modality strategies include induction chemotherapy (chemotherapy preceding ...
openaire   +2 more sources

Mechanism study of lncRNA RMRP regulating esophageal squamous cell carcinoma through miR-580-3p/ATP13A3 axis

open access: yesDiscover Oncology
Objective It is well-known that lncRNAs regulate energy metabolism in tumors. This study focused on the action of RMRP on esophageal squamous cell carcinoma (ESCC) cell proliferation, apoptosis, and glycolysis.
ZiRui Tan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy